Global Drugs for Osteoarthritis Pain Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Drugs for Osteoarthritis Pain Market Overview

• 1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
• 1.2 Classification of Drugs for Osteoarthritis Pain by Types
  • 1.2.1 Global Drugs for Osteoarthritis Pain Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Types in 2018
  • 1.2.3 Oral
  • 1.2.4 Injection
  • 1.2.5 External
• 1.3 Global Drugs for Osteoarthritis Pain Market by Application
  • 1.3.1 Global Drugs for Osteoarthritis Pain Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Medical Care
  • 1.3.3 Personal Care
• 1.4 Global Drugs for Osteoarthritis Pain Market by Regions
  • 1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
• 1.5 Global Market Size of Drugs for Osteoarthritis Pain (2014-2024)

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Johnson & Johnson
  • 2.2.1 Business Overview
  • 2.2.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 GlaxoSmithKline
  • 2.3.1 Business Overview
  • 2.3.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bayer
  • 2.4.1 Business Overview
  • 2.4.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Eli Lilly
  • 2.5.1 Business Overview
  • 2.5.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Novartis
  • 2.6.1 Business Overview
  • 2.6.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sanofi
  • 2.7.1 Business Overview
  • 2.7.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Horizon Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Abbott
  • 2.9.1 Business Overview
  • 2.9.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Mylan
  • 2.10.1 Business Overview
  • 2.10.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Daiichi Sankyo
  • 2.11.1 Business Overview
  • 2.11.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 TEVA
  • 2.12.1 Business Overview
  • 2.12.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Almatica Pharma
  • 2.13.1 Business Overview
  • 2.13.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Astellas Pharma
  • 2.14.1 Business Overview
  • 2.14.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Tide Pharmaceutical
  • 2.15.1 Business Overview
  • 2.15.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Iroko Pharmaceuticals
  • 2.16.1 Business Overview
  • 2.16.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Hengrui Pharmaceutical
  • 2.17.1 Business Overview
  • 2.17.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Abiogen Pharma
  • 2.18.1 Business Overview
  • 2.18.2 Drugs for Osteoarthritis Pain Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)

3 Global Drugs for Osteoarthritis Pain Market Competition, by Players

• 3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Drugs for Osteoarthritis Pain Players Market Share
  • 3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share
• 3.3 Market Competition Trend

4 Global Drugs for Osteoarthritis Pain Market Size by Regions

• 4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions
• 4.2 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 4.3 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 4.5 South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

5 North America Drugs for Osteoarthritis Pain Revenue by Countries

• 5.1 North America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
• 5.2 USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 5.3 Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

6 Europe Drugs for Osteoarthritis Pain Revenue by Countries

• 6.1 Europe Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
• 6.2 Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 6.3 UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 6.4 France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 6.5 Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 6.6 Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries

• 7.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
• 7.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 7.3 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 7.4 Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 7.5 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

8 South America Drugs for Osteoarthritis Pain Revenue by Countries

• 8.1 South America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
• 8.2 Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Drugs for Osteoarthritis Pain by Countries

• 9.1 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 9.3 UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)

10 Global Drugs for Osteoarthritis Pain Market Segment by Type

• 10.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2014-2019)
• 10.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2019-2024)
• 10.3 Oral Revenue Growth Rate (2014-2024)
• 10.4 Injection Revenue Growth Rate (2014-2024)
• 10.5 External Revenue Growth Rate (2014-2024)

11 Global Drugs for Osteoarthritis Pain Market Segment by Application

• 11.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2014-2019)
• 11.2 Drugs for Osteoarthritis Pain Market Forecast by Application (2019-2024)
• 11.3 Medical Care Revenue Growth (2014-2019)
• 11.4 Personal Care Revenue Growth (2014-2019)

12 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)

• 12.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
• 12.2 Global Drugs for Osteoarthritis Pain Market Forecast by Regions (2019-2024)
• 12.3 North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
• 12.4 Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
• 12.6 South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology